11 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
and enforcement by state authorities as well as significant reputational harm. We are currently subject to the HIPAA regulations and maintain an active … in our suffering significant financial or reputational damage. Each of our tests is processed in a single one of our laboratory facilities, and any loss
ARS
2022 FY
MYGN
Myriad Genetics, Inc.
12 Apr 23
Annual report to shareholders
4:10pm
financial or reputational damage. Table of Contents 35
Each of our tests is processed in a single one of our laboratory facilities, and any loss
10-KT
MYGN
Myriad Genetics, Inc.
16 Mar 21
Annual report (with FYE transition)
2:24pm
result in civil and/or criminal penalties, significant reputational damage and could have a material adverse effect on our business.
The General Data
- Prev
- 1
- Next